share_log

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target

HC Wainwright & Co.重申買入Microbot Medical,維持8美元的目標股價
Benzinga ·  2023/10/18 07:21

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $8 price target.

HC Wainwright&Co.分析師Raghuram Selvaraju重申微博特醫療(納斯達克:MBOT)的買入,並維持8美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論